The Bristol Myers Squibb Immuno-Oncology Podcast is dedicated to keeping listeners updated on current findings in the immuno-oncology treatment landscape.
All content for The Immuno-Oncology Podcast is the property of Bristol Myers Squibb and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
The Bristol Myers Squibb Immuno-Oncology Podcast is dedicated to keeping listeners updated on current findings in the immuno-oncology treatment landscape.
Special guest Shilpa Gupta, MD joins us to discuss the various ways to individually approach the adjuvant treatment setting for your patients with radically resected urothelial carcinoma along with their multidisciplinary care team. Dr. Gupta is a genitourinary oncologist at the Cleveland Clinic. Dr Gupta is a paid consultant of BMS.
This podcast was sponsored by Bristol-Myers Squibb Company.
The Bristol Myers Squibb Immuno-Oncology Podcast is dedicated to keeping listeners updated on current findings in the immuno-oncology treatment landscape.
